login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
RAPT THERAPEUTICS INC (RAPT) Stock News
NASDAQ:RAPT -
US75382E1091
-
Common Stock
11.3
USD
-0.57 (-4.8%)
Last: 9/3/2025, 4:30:01 PM
11.3
USD
0 (0%)
After Hours:
9/3/2025, 4:30:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RAPT Latest News, Press Relases and Analysis
All
Press Releases
7 days ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
7 days ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
16 days ago - By: Zacks Investment Research
Wall Street Analysts Think Rapt Therapeutics (RAPT) Could Surge 101.02%: Read This Before Placing a Bet
22 days ago - By: Zacks Investment Research
Rapt Therapeutics (RAPT)'s Technical Outlook is Bright After Key Golden Cross
a month ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Reports Second Quarter 2025 Financial Results
8 months ago - By: Benzinga
- Mentions:
PGR
EVER
This Progressive Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday
a month ago - By: Zacks Investment Research
Wall Street Analysts Believe Rapt Therapeutics (RAPT) Could Rally 122.22%: Here's is How to Trade
2 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Names Two Industry Veterans to its Board of Directors
2 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Names Two Industry Veterans to its Board of Directors
8 months ago - By: Benzinga
Why RAPT Therapeutics Stock Gained Over 100% On Monday?
3 months ago - By: Yahoo Finance
- Mentions:
FIS
JNVR
COIN
PSX
...
SOL Rebounds Toward $145 as 7 ETFs Advance and DeFi Dev Corp Eyes More SOL Purchases
3 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split
3 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split
3 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics to Participate in Upcoming Investor Conferences
3 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics to Participate in Upcoming Investor Conferences
4 months ago - By: Zacks Investment Research
Rapt Therapeutics (RAPT) Upgraded to Buy: Here's What You Should Know
4 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Reports First Quarter 2025 Financial Results
4 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Reports First Quarter 2025 Financial Results
5 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
5 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
6 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics to Participate in Upcoming Investor Conferences
6 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics to Participate in Upcoming Investor Conferences
6 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
6 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
8 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
8 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
8 months ago - By: RAPT Therapeutics, Inc.
RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors
8 months ago - By: RAPT Therapeutics, Inc.
- Mentions:
CTNM
RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors
8 months ago - By: Yahoo Finance
- Mentions:
RJF
PGR
EVER
Progressive, EverQuote upgraded: Wall Street's top analyst calls
Please enable JavaScript to continue using this application.